Evidence of Lifestyle Modification in the Management of Hypercholesterolemia
Open Access
- 1 February 2013
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Cardiology Reviews
- Vol. 9 (1), 2-14
- https://doi.org/10.2174/157340313805076313
Abstract
Abstract: Background: Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. The growth of ageing populations in developing countries with progressively urbanized lifestyles are major contributors. The key risk factors for CHD such as hypercholesterolemia, diabetes mellitus, and obesity are likely to increase in the future. These risk factors are modifiable through lifestyle. Objectives: To review current literature on the potential benefit of cholesterol lowering in CHD risk reduction with a particular focus on the evidence of non-pharmacological/lifestyle management of hypercholesterolemia. Methods: Medline/PubMed systematic search was conducted using a two-tier approach limited to all recent English language papers. Primary search was conducted using key words and phrases and all abstracts were subsequently screened and relevant papers were selected. The next tier of searching was conducted by (1) reviewing the citation lists of the selected papers and (2) by using PubMed weblink for related papers. Over 3600 reports were reviewed. Results: Target cholesterol levels set out in various guidelines could be achieved by lifestyle changes, including diet, weight reduction, and increased physical activity with the goal of reducing total cholesterol to Conclusion: CHD remains as a leading cause of death worldwide and hypercholesterolemia is an important cause of CHD. Non-pharmacological methods provide initial as well as long-term measures to address this issue.Keywords
This publication has 102 references indexed in Scilit:
- Aerobic exercise and lipids and lipoproteins in children and adolescents: A meta-analysis of randomized controlled trialsAtherosclerosis, 2007
- Cardiothoracic ratio within the "normal" range independently predicts mortality in patients undergoing coronary angiographyHeart, 2007
- Antiatherosclerotic and Antithrombotic Effects of Omega-3 Fatty AcidsThe American Journal of Cardiology, 2006
- Guggul for hyperlipidemia: A review by the Natural Standard Research CollaborationComplementary Therapies in Medicine, 2005
- Prescribing Exercise at Varied Levels of Intensity and FrequencyArchives of Internal Medicine, 2005
- Practical Implementation of the Guidelines for Unstable Angina/Non–ST-Segment Elevation Myocardial Infarction in the Emergency DepartmentCirculation, 2005
- Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normalJournal of the American College of Cardiology, 2004
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsThe New England Journal of Medicine, 1998
- Compared With Dietary Monounsaturated and Saturated Fat, Polyunsaturated Fat Protects African Green Monkeys From Coronary Artery AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Dietary lipids and thrombosis. Relationships to atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990